Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.
Australian researchers say they have developed an accurate blood test to detect the first stages of ovarian cancer.
Gynecologic Oncology, the prestigious medical journal of the Society for Gynecologic Oncology, has published the second prospective clinical study of OVA1 which demonstrated the positive performance of the multi-biomarker test in the triage of early-stage ovarian cancer.
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
British researchers say a new blood test which is able to detect signs of breast cancer four years earlier than it would be picked up by a standard mammogram, could be available within months.
Noninvasive contrast-enhanced ultrasound imaging, combined with proteomic analyses of blood samples may help physicians identify early-stage ovarian cancer and save the lives of many women, according to an article published in the February issue of the American Journal of Roentgenology.
Researchers have developed a simple blood test that can detect over 50 types of cancer, often before signs or symptoms.
Leadership of U.S. Rep. Steve Israel, support from The Lynne Cohen Foundation, Row for a Cure and Totino Research Fund bring cutting edge research to Long Island.